Conference - United States
Now in its 14th year, the “Immunogenicity for Biotherapeutics” conference has witnessed the development of new classes of biomolecules from theory to blockbuster and has consistently been the site for state-of-the-art discussion and technical improvements in molecular safety and immunoprofiling.This year’s agenda offers you over 10 case studies that bridge both ever-present challenges of assay design and advanced de-risking strategies for the next generation of biomolecules. No other conference offers more extensive analysis of maximizing the safety of these new classes of molecules! Our faculty helps you: • Optimize your risk minimization strategies to cover the entire preclnical-to-clinical life cycle • Create and capitalize on the most advanced transgenic animal models to get the best grasp on predicting immunogenicity • Identify the must-have features of molecular design to minimize or eliminate epitopes • Adapt your skills to the unique features of newly-developed varieties of biomolecules, including biosimilars, nanomedicines, bispecifics and antibody-drug conjugates Also backed by popular demand, the return of “Immunogenicity University” an intensive full-day summit offering practical guidance for day-to-day challenges in order to make sure all of our participants are equally equipped to handle the more novel and in-depth case studies to follow.
March 18, 2013 - March 20, 2013 (7:45am)
Institute for International Research
Baltimore, Maryland, USA
Contact: Roxana Siu (firstname.lastname@example.org)
Phone: (888) 670-8200
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.